Skip to main content
. 2015 Apr 23;10(4):e0122102. doi: 10.1371/journal.pone.0122102

Table 2. The number (N = 231) and proportion of moose positive for HEV RNA and/or anti-HEV antibody detected in serum, feces or liver, arranged according to age class, gender and Swedish county.

Variable (N) With anti-HEV (N) (%, 95% Cl) Reactive for HEV RNA (N) (%, 95% Cl) Total HEV markers* (N) (Both markers) (%, 95% Cl)
Age (years)
0–1.5 107 12 (11.2%; 6.0–19.2) 18 (16.8%, 10–25) 26 (4) (26%, 18–35.2)
2–4.5 65 17 (26.2%, 16.0–38.5) 7 (10.8%, 4.4–20.9) 21 (3) (32.3%, 21.2–45)
5.5–15.5 35 6 (17.4%, 6.6–33.7) 5 (14.3%, 4.8–30.3) 8 (3) (22.9%, 10.4–40.1)
Unknown 24 8 (33.3%, 16.4–55.3) 4 (16.7%, 4.7–37.4) 12 (0) (50%, 29.1–70.9)
Gender
Male 89 14 (15.7%, 8.9–25) 14 (15.7%, 8.9–25) 24 (4) (27%, 18.1–37.2)
Female 97 21 (21.6%, 13.9–31.2) 9 (9.3%, 4.3–16.9) 26 (4) (26.8%, 18.3–36.8)
Unknown 45 8 (17.8%, 8–32) 11 (24.4%, 12.9–39.5) 17 (2) (37.8%, 23.8–53.5)
Swedish county
Öland 49 9 (18.4%, 9.2–32.5) 3 (6.1%, 1.6–17.9) 11 (1) (22.4%, 12.2–37.0)
Småland 51 9 (17.6%, 8.9–31.4) 4 (7.8%, 2.5–19.7) 10 (3) (19.6%, 10.3–33.5)
Västergötland 33 10 (30.3%, 16.2–48.9) 6 (18.2%, 7.6–36.1) 13 (3) (39.4%, 23.4–57.8)
Södermanland 77 13 (16.9%, 9.6–27.5) 19 (24.7%, 15.9–36.0) 29 (3) (37.7%, 27.1–49.5)
Västermanland 10 1 (10%, 5,2–45.9) 2 (20.0%, 0.30–55.8) 3 (0) (30%, 8,1–64.6)
Värmland 3 1 (33.3%, 0.2–84.4) 0 (0, 0–0,7) 1 (0) (33.3%, 18–87.7)
Västerbotten 8 0 (0%, 0–40.2) 0 (0,0–40.2) 0 (0) (0,0–40.2)
Total 231** 43 (18.6%, 13.9–24.4) 34 (14.7%, 10.5–20.1) 67 (10) (29%, 23.3–35.4)

* = 10 animals had both HEV-specific antibodies and HEV RNA detectable in their samples.

** = for 51 animals, both serum and fecal samples were available, 10 had detectable HEV RNA in feces, 6 of those had HEV RNA also in their serum samples.